• 1. A novel tripodal tris-hydroxypyrimidinone sequestering agent for trivalent hard metal ions: synthesis, complexation and in vivo studies
  Sílvia Chaves,Anabela Capelo,Laurinda Areias,Sérgio M. Marques,Lurdes Gano,M. Alexandra Esteves,M. Amélia Santos Dalton Trans. 2013 42 6033
• 2. Structural motifs of diiodine complexes with amides and thioamides
  Ioanna-Efpraxia Parigoridi,Ghada J. Corban,Sotiris K. Hadjikakou,Nick Hadjiliadis,Nikolaos Kourkoumelis,George Kostakis,Vassilis Psycharis,Catherine P. Raptopoulou,Maciej Kubicki Dalton Trans. 2008 5159
• 3. Weak ferromagnetism in chiral diamond-like neutral networks: Mn(2-pymS)2 and Co(2-pymS)2 (2-pymSH = 2-mercaptopyrimidine)
  Jing Zhang,Song Gao,Xi-Xiang Zhang,Zhe-Ming Wang,Chi-Ming Che Dalton Trans. 2012 41 2626
• 4. 224. An experimental study of some potentially tautomeric 2- and 4(6)-substituted pyrimidines
  J. R. Marshall,James Walker J. Chem. Soc. 1951 1004
• 5. Heteroleptic pyrimidine-2-olate and 4,4′-bipyridine copper(ii) layered metal–organic frameworks with swelling properties
  Elisa Barea,Miguel Quirós,Jorge A. R. Navarro,Juan M. Salas Dalton Trans. 2005 1743

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Pyrimidones

Introduction to 1,2-dihydropyrimidin-2-one hydrochloride (CAS No. 38353-09-2)

1,2-dihydropyrimidin-2-one hydrochloride, identified by the Chemical Abstracts Service registry number 38353-09-2, is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This heterocyclic organic compound belongs to the dihydropyrimidine class, which has garnered considerable attention due to its versatile structural framework and potential biological activities. The hydrochloride salt form enhances its solubility and stability, making it a valuable intermediate in synthetic chemistry and drug development pipelines.

The molecular structure of 1,2-dihydropyrimidin-2-one hydrochloride consists of a six-membered ring containing two nitrogen atoms and one oxygen atom, with a hydrochloride moiety attached to the second carbon atom of the ring. This configuration imparts unique reactivity and functional properties, enabling its incorporation into various pharmacophores. The compound’s ability to act as a scaffold for bioactive molecules has been exploited in the design of novel therapeutic agents targeting diverse disease mechanisms.

In recent years, 1,2-dihydropyrimidin-2-one hydrochloride has been extensively studied for its role in medicinal chemistry, particularly in the synthesis of kinase inhibitors and other small-molecule drugs. Its structural motif is reminiscent of nucleoside analogs, which have demonstrated efficacy in treating viral infections and cancer. The compound’s versatility as a building block allows for modifications at multiple positions, facilitating the development of derivatives with enhanced pharmacokinetic profiles and target specificity.

One of the most compelling aspects of 1,2-dihydropyrimidin-2-one hydrochloride is its involvement in the development of antiviral agents. Researchers have leveraged its scaffold to create inhibitors that disrupt viral polymerase enzymes, offering promising candidates for therapies against emerging pathogens. Additionally, its application in anticancer research has shown promise, particularly in targeting tyrosine kinases that play a crucial role in tumor proliferation and survival. The compound’s ability to modulate these kinases has been explored through computational modeling and experimental validation.

The synthesis of 1,2-dihydropyrimidin-2-one hydrochloride typically involves condensation reactions between urea or thiourea derivatives with β-ketoesters or β-ketoamides under acidic conditions. The resulting dihydropyrimidinone can then be converted into its hydrochloride salt to improve handling properties. Advances in synthetic methodologies have enabled more efficient and scalable production processes, allowing for greater accessibility of this compound for research purposes. These improvements have been instrumental in accelerating drug discovery efforts across academic institutions and pharmaceutical companies.

From a computational chemistry perspective, 1,2-dihydropyrimidin-2-one hydrochloride has been subjected to extensive molecular dynamics simulations to understand its interactions with biological targets. These studies have provided insights into how the compound binds to proteins and enzymes, guiding the optimization of lead structures. Furthermore, virtual screening techniques have been employed to identify potential drug candidates derived from this scaffold, streamlining the hit-to-lead process in drug development.

The pharmacological profile of derivatives of 1,2-dihydropyrimidin-2-one hydrochloride has been evaluated through preclinical studies, revealing promising activities against various pathological conditions. For instance, certain analogs have shown inhibitory effects on platelet-derived growth factor receptors (PDGFRs), which are implicated in fibrosis and tumor angiogenesis. Such findings underscore the therapeutic potential of this class of compounds and highlight their relevance in addressing unmet medical needs.

Regulatory considerations also play a critical role in the development and commercialization of drugs based on 1,2-dihydropyrimidin-2-one hydrochloride. Compliance with Good Manufacturing Practices (GMP) ensures that pharmaceutical-grade materials are produced consistently and safely. Additionally, rigorous toxicological assessments are conducted to evaluate potential side effects before human clinical trials commence. These regulatory milestones are essential for ensuring patient safety while advancing therapeutic options derived from this compound.

The future directions for research involving 1,2-dihydropyrimidin-2-one hydrochloride are multifaceted. Exploration into its role as a prodrug or co-administered agent could expand its therapeutic applications further. Moreover, interdisciplinary approaches combining organic synthesis with bioinformatics may uncover novel derivatives with improved efficacy and reduced toxicity. As our understanding of disease mechanisms evolves, so too will the opportunities for leveraging this versatile scaffold in drug discovery.

In conclusion,1,2-dihydropyrimidin-2-one hydrochloride (CAS No. 38353-09-2) represents a cornerstone in modern medicinal chemistry due to its structural versatility and biological relevance. Its contributions to antiviral and anticancer therapies underscore its importance as a pharmacophoric scaffold. With ongoing advancements in synthetic methodologies and computational techniques,1,2-dihydropyrimidin-2-one hydrochloride continues to be a focal point for innovation across academia and industry alike.

• 931-63-5(2-Methoxypyrimidine)
• 284682-24-2(2-Pyrimidinyloxy)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)